291 related articles for article (PubMed ID: 18469028)
41. Intractable ascites, changes in serum vascular endothelial growth factor levels and thalidomide treatment in POEMS syndrome.
Wu KL; Chen HW; Lin SH; Chen JS
Am J Med Sci; 2014 Jun; 347(6):510-2. PubMed ID: 24781436
[No Abstract] [Full Text] [Related]
42. POEMS syndrome with undetectable M-protein: a case report and literature review.
Xue HY; Zhou L; Yuan QZ; Zhang Y; Hao YQ; Chen SW; Wang HK; Wei F
Diagn Pathol; 2024 Jun; 19(1):74. PubMed ID: 38849857
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.
Vannata B; Laurenti L; Chiusolo P; Sorà F; Balducci M; Sabatelli M; Luigetti M; Giannotta C; De Stefano V; Leone G; Sica S
Am J Hematol; 2012 Jun; 87(6):641-2. PubMed ID: 22488443
[TBL] [Abstract][Full Text] [Related]
44. Correlation between serum level of vascular endothelial growth factor and subfoveal choroidal thickness in patients with POEMS syndrome.
Yokouchi H; Baba T; Misawa S; Sawai S; Beppu M; Kitahashi M; Oshitari T; Kuwabara S; Yamamoto S
Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1641-6. PubMed ID: 25367833
[TBL] [Abstract][Full Text] [Related]
45. POEMS syndrome with Guillan-Barre syndrome-like acute onset: a case report and review of neurological progression in 30 cases.
Isose S; Misawa S; Kanai K; Shibuya K; Sekiguchi Y; Nasu S; Fujimaki Y; Noto Y; Nakaseko C; Kuwabara S
J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):678-80. PubMed ID: 20562460
[TBL] [Abstract][Full Text] [Related]
46. [Crow-Fukase (POEMS) syndrome].
Kuwabara S
Brain Nerve; 2010 Apr; 62(4):395-400. PubMed ID: 20420180
[TBL] [Abstract][Full Text] [Related]
47. An Adult with Polyneuropathy and Hypogonadism due to Poems Syndrome.
Zaidi S; Sattar S; Asumal KB
J Coll Physicians Surg Pak; 2017 Oct; 27(10):651-653. PubMed ID: 29056130
[TBL] [Abstract][Full Text] [Related]
48. [New elements in the diagnosis and the treatment of primary AL amyloid polyneuropathy and neuropathy due to POEMS syndrome].
Adams D; Lozeron P; Theaudin M; Ribrag V; Bourhis JH; Lacroix C
Rev Neurol (Paris); 2011 Jan; 167(1):57-63. PubMed ID: 21190703
[TBL] [Abstract][Full Text] [Related]
49. Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome.
Karam C; Klein CJ; Dispenzieri A; Dyck PJ; Mandrekar J; D'Souza A; Mauermann ML
Neurology; 2015 May; 84(19):1981-7. PubMed ID: 25878176
[TBL] [Abstract][Full Text] [Related]
50. An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.
Drake MJ; Robson W; Mehta P; Schofield I; Neal DE; Leung HY
Br J Cancer; 2003 Mar; 88(6):822-7. PubMed ID: 12644816
[TBL] [Abstract][Full Text] [Related]
51. New advances in the diagnosis and treatment of POEMS syndrome.
Li J; Zhou DB
Br J Haematol; 2013 May; 161(3):303-15. PubMed ID: 23398538
[TBL] [Abstract][Full Text] [Related]
52. POEMS Syndrome: Therapeutic Options.
Jaccard A
Hematol Oncol Clin North Am; 2018 Feb; 32(1):141-151. PubMed ID: 29157615
[TBL] [Abstract][Full Text] [Related]
53. Successful treatment with rituximab and thalidomide of POEMS syndrome associated with Waldenstrom macroglobulinemia.
Kawano Y; Nakama T; Hata H; Kimura E; Maruyoshi N; Uchino M; Mitsuya H
J Neurol Sci; 2010 Oct; 297(1-2):101-4. PubMed ID: 20673674
[TBL] [Abstract][Full Text] [Related]
54. [POEMS syndrome. An interdisciplinary clinical challenge].
Braun SA; Albrecht P; Methner A; Hanneken S
Hautarzt; 2011 Oct; 62(10):722-5. PubMed ID: 21915731
[TBL] [Abstract][Full Text] [Related]
55. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
[TBL] [Abstract][Full Text] [Related]
56. Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study.
Briani C; Dalla Torre C; Lessi F; Cavallaro T; Scarlato M; Ferrari S; Campagnolo M; Lucchetta M; Cabrini I; Morbin M; Lauria G; Adami F; Manfredi AA
J Neuroimmunol; 2014 Dec; 277(1-2):189-92. PubMed ID: 25447599
[TBL] [Abstract][Full Text] [Related]
57. Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.
Ma L; Wang Y; Bo J; Han W; Wang Y; Zhang L; Wu X; Yu S; Liu R
Clin Exp Immunol; 2016 Apr; 184(1):83-9. PubMed ID: 26660736
[TBL] [Abstract][Full Text] [Related]
58. [Two cases of POEMS syndrome with increased vascular endothelial growth factor (VEGF)].
Arimura H; Watanabe O; Arimura K; Maruyama I; Hokezu Y
Rinsho Shinkeigaku; 1997 Sep; 37(9):817-23. PubMed ID: 9430997
[TBL] [Abstract][Full Text] [Related]
59. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2019 Jul; 94(7):812-827. PubMed ID: 31012139
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome.
Cheng S; Huang L; Fan W; Liang D; Zhu X; Jiang S; Ge Y
Int Urol Nephrol; 2022 Sep; 54(9):2317-2325. PubMed ID: 35133575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
